At a glance
ClinicalIndex Comparison RecordN/ACompleted· 108 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Application of the One-step Nucleic Acid Amplification (OSNA) Assay to Detect Free Cancer Cells in the Peritoneal Washing of Gastric and Colon Cancer Patients
In Brief
An observational study for Peritoneal Carcinomatosis. Completed, enrolled 108 participants across 1 site.
Detailed Summary
In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeritoneal Carcinomatosis
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartJul 2024
Primary CompletionOct 2025
Study CompletionFeb 2026
First PostedMar 2026
TodayJul 2026
First PostedMar 17, 2026
Enrollment StartJul 1, 2024
Primary CompletionOct 31, 2025
Study CompletionFeb 28, 2026
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4 months ago